secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2025-12-05T23:59:59+00:00
Accession:  0001493152-25-026385
Event type: other
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics shareholders approve reverse stock split up to 1-for-30
----------------------------------------------------------------------

- Special meeting on Dec 5, 2025 approved amendment for reverse stock split.
- Vote: 26,465,960 for, 4,213,378 against, 194,746 abstain – passed.
- Board authorized to set final ratio between 1-for-2 and 1-for-30 within 12 months.
- No other proposals were voted on at the special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315225026385/0001493152-25-026385-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315225026385/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-026385

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer